SCHEMBL6040035

SCHEMBL6040035

O=C(C(=O)N1CCOCC1)N1CCCC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.62
TP53 P04637 1/20 0.62
KMT2A Q03164 1/20 0.62
SMN1; SMN2 Q16637 3/20 0.52
CA12 O43570 2/20 0.52
CA1 P00915 2/20 0.52
CA9 Q16790 2/20 0.52
MMP1 P03956 1/20 0.48
MMP3 P08254 1/20 0.48
MMP8 P22894 1/20 0.48
PKM P14618 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
PDK1 Q15118 1/20 0.45
PDK2 Q15119 1/20 0.45
PDK3 Q15120 1/20 0.45
HTT P42858 1/20 0.43
TSHR P16473 1/20 0.43
CA2 P00918 1/20 0.42
HPGD P15428 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8674256 0.97 MEN1 (0.60) MEN1TP53KMT2ASMN1; SMN2CA12
SCHEMBL786679 0.92 SMN1; SMN2 (0.59) MEN1TP53KMT2ASMN1; SMN2CA12
SCHEMBL3954355 0.84 MEN1 (0.86) MEN1TP53KMT2ASMN1; SMN2CA12
SCHEMBL8288869 0.83 ALDH1A1 (0.56) TP53SMN1; SMN2CA12CA1CA9
SCHEMBL4305149 0.82 MEN1 (0.82) MEN1TP53KMT2ASMN1; SMN2CA12
SCHEMBL2202342 0.82 MEN1 (0.82) MEN1TP53KMT2ASMN1; SMN2CA12
SCHEMBL419264 0.81 CA12 (0.54) MEN1TP53KMT2ASMN1; SMN2CA12
SCHEMBL11889662 0.80 ALDH1A1 (0.58) MEN1TP53KMT2ASMN1; SMN2CA12
SCHEMBL8024247 0.80 ALDH1A1 (0.61) MEN1KMT2ACA12CA1CA9
SCHEMBL4261207 0.80 ALDH1A1 (0.61) MEN1KMT2ACA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060094724-A1 Fused furan compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2006-05-04 US claimed
EP-0313974-A1 N-substituted derivatives of 1-desoxynojirimycine and 1-desoxymannonojirimycine, process for their preparation and their use as pharmaceuticals BAYER AG (DE) 1989-05-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094724-A1 Fused furan compound F2, F12, F11 MEN1 1870/4885TP53 3516/4885KMT2A 1957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.